Individual Study / WHI

Women's Health Initiative

Women's Health Initiative

WHI logo
Initiatives -
Start Year
1992
End Year
2007
Funding
National Heart, Lung, and Blood Institute and NHLBI
Supplementary Information
https://www.nhlbi.nih.gov/science/womens-health-initiative-whi
Visit WHI

Members

Download
Investigators Contacts
  • Dr. Garnet Anderson
    Public Health Sciences Division, Fred Hutch
  • Dr. Prof. Sally A. Shumaker
    Wake Forest School of Medicine

Design

Study design
Other : Clinical Trial; Observational study
Follow Up
Women in the clinical trial are followed through regularly scheduled examinations to ensure the timely ascertainment of updated medical histories, tomonitor the occurrence of possible adverse effects, to dispense study medications, and to promote adherence to the study protocol. Observational study (OS) participants are contacted annually by mail to obtain updates of their medical histories and selected exposure data. At about 3 years after enrollment, all OS participants are invited to a clinic follow-up visit to update selected baseline data, to obtain additional risk factor data, and to collect a blood specimen.
Supplementary Information
https://en.wikipedia.org/wiki/Women%27s_Health_Initiative

Marker Paper

Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials. 1998 Feb;19(1):61-109. doi: 10.1016/s0197-2456(97)00078-0.

PUBMED 9492970

Recruitment

Sources of Recruitment
  • Individuals

Number of participants

Number of participants
161,000
Number of participants with biosamples
Supplementary Information
Post-menopausal women. The average age of women still active in WHI is 83 years and ranges from 71 to 103 years.

Access

Availability of data and biosamples

Data
Biosamples
Other

Availability of access information

On the study website : https://www.whi.org/